ADAR1 Capital
ADAR1 Capital Management is a biotechnology and healthcare-focused hedge fund managing over $1.3B AUM, with investments in clinical-stage biotechs and notable exits like Evommune.
5+ investments · 5 portfolio companies
- AUM
- $1.4B
- Portfolio Companies
- 5
- Total Investments
- 5
- Last Investment
- Apr 2026
Overview
ADAR1 Capital is a Hedge Fund firm. It has made 5 investments, including Acumen Pharmaceuticals, Kalaris Therapeutics and Fractyl Health. Focus areas include Biotech and Healthcare.
Portfolio5
Co-investors24
Sign up to view co-investors
24 co-investors across 26 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×15 · Hedge Fund ×3 · Family Office ×2 · 8 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/adar1-capital"><img src="https://indexed.vc/api/badge/investor/adar1-capital" alt="ADAR1 Capital on Indexed.vc" width="260" height="76" /></a>